PacBio Q4 Revenues Climb 115 Percent on Roche Payment | GenomeWeb

This story has been updated to include comments from PacBio's earnings call.

NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Wednesday that its fourth quarter 2015 revenues increased 114 percent over the fourth quarter 2014.

The Menlo Park, California-based single-molecule sequencing technology company reported Q4 2015 revenues of $36.3 million, up from $16.9 million in the prior-year period but missing analysts' consensus estimate of $37.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.

Dec
13
Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Dec
15
Sponsored by
PierianDx

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.